Atezolizumab

Hepatitis and thrombocytopenia: case report

    This is a preview of subscription content, log in to check access.

    Reference

    1. Tsukita Y, et al. Immunotherapy-related hepatitis and thrombocytopaenia induced by the very low dose of only 90 mg of atezolizumab. European Journal of Cancer 133: 22-24, Jul 2020. Available from: URL: http://doi.org/10.1016/j.ejca.2020.04.008

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Atezolizumab. Reactions Weekly 1809, 55 (2020). https://doi.org/10.1007/s40278-020-79839-5

    Download citation